By Deron Hamel Results from an early phase clinical trial suggest that cannabidiol (CBD) may be an effective treatment for stemming the number of seizures for people living with severe, drug-resistant forms of epilepsy, however, randomized controlled trials are needed before conclusions can be drawn on the chemical compound’s effectiveness, says Dr. Elizabeth Donner. While…
Update (July 6, 2015): The acetazolamide shortage has been resolved. Acetazolamide tablets are available again from AA Pharma. The Drug Identification Number or DIN is 00545015. Please note that Acetazolam (Valeant Canada LP) is no longer available, this product has been discontinued. Drug Identification Number or DIN is 00295019. If you need any assistance please let…
By Deron Hamel Dr. Carter Snead says the best possible long-term result from new provincial epilepsy-care guidelines would be for primary-care physicians, neurologists and patients to use the standards to enhance care of Ontarians with seizure disorders. The Provincial Guidelines for the Management of Epilepsy in Adults and Children creates a framework for general practitioners…
By Deron Hamel A prominent Toronto neurologist says the recent establishment of the Provincial Guidelines for the Management of Epilepsy in Adults and Children is an important step forward in creating consistent epilepsy care in Ontario. Dr. Carter Snead, a neurologist at Toronto’s Hospital for Sick Children (SickKids), says the greatest overall changes he hopes…
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
Sponsor Image 1
Sponsor Image 2
Sponsor Image 3
